Implantable Drug Eluting Devices Market. The Global Implantable Drug Eluting Devices Market was valued at approximately USD ...

Global Drug-Eluting Stents Market is valued at approximately USD 7.37 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.6% over the forecast period 2023-2030.

Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.

The burden of cardiovascular diseases (CVDs) among smokers is profoundly evident, cigarette smoking, a leading preventable ...

Teleflex Incorporated announced it has entered into a definitive agreement to acquire substantially all of the Vascular ...

Teleflex is splitting its business into two independently traded entities, with a completion date set for mid-2026 ...

We value keeping the Device Guide up to date.

It is driven by advancements in material science and miniaturisation. The global balloon catheters market, valued at $4.4b in ...

Since the advent of drug-eluting stents, there has been a debate in the intervention community over how long dual ...

Medical devices provider, Teleflex (NYSE:TFX) said on Thursday that it will acquire all of the vascular intervention business ...

THIRUVANANTHAPURAM: Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) has launched two innovative drug-eluting bone graft products. The products were unveiled by ...